Literature DB >> 29655569

Activation of the porcine alveolar macrophages via toll-like receptor 4/NF-κB mediated pathway provides a mechanism of resistin leading to inflammation.

Bi Li1, Jing Fang1, Zhicai Zuo2, Sirui Yin1, Tingting He1, Mingxian Yang1, Junliang Deng1, Liuhong Shen1, Xiaoping Ma1, Shumin Yu1, Ya Wang1, Zhihua Ren1, Hengmin Cui1.   

Abstract

Resistin, a previously discovered cysteine-rich adipokine known to regulate glucose metabolism, has been emerged as a mediator in inflammation and immunity. Its level was supposed to be related to the expression of indicators, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in inflammation. Toll-like receptor 4 (TLR4) was reported to be a receptor for resistin in cells, like leukocytes and peripheral blood mononuclear cells (PBMC). However, the pro-inflammatory role of resistin and its intracellular mechanisms in alveolar macrophages have not been thoroughly validated. Here we found that the pro-inflammatory cytokine expression in porcine alveolar macrophages (PAMs) was positively correlated with resistin. Our results also showed that resistin induced the expression of TLR4, intracellular molecules myeloid differentiation primary response protein 88 (MyD88), TRIF-related adaptor molecule (TRAM) and nuclear factor κB (NF-κB) in PAMs. In contrast, inhibition of TLR4, MyD88, TRAM and NF-κB abrogated the pro-inflammatory effect of resistin on PAMs. Additionally, the associations among TLR4, MyD88/TRAM and NF-κB were investigated by introducing TLR4-siRNA, MyD88-siRNA and TRAM-siRNA respectively into PAMs prior to the treatment with resistin. Taken together, our findings demonstrated that resistin promoted the production of pro-inflammatory cytokine in PAMs via TLR4/NF-κB-mediated pathway (TLR4/MyD88/TRAM/NF-κB).
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveolar macrophages; Inflammation; Nuclear factor κB; Resistin; Toll-like receptor 4

Mesh:

Substances:

Year:  2018        PMID: 29655569     DOI: 10.1016/j.cyto.2018.04.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Resistin: An inflammatory cytokine with multi-faceted roles in cancer.

Authors:  Sarabjeet Kour Sudan; Sachin Kumar Deshmukh; Teja Poosarla; Nicolette Paolaungthong Holliday; Donna Lynn Dyess; Ajay Pratap Singh; Seema Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-08-19       Impact factor: 10.680

2.  Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation.

Authors:  Liang Zhou; Xiaoling Hang; Lei Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 3.  An Update on the Emerging Role of Resistin on the Pathogenesis of Osteoarthritis.

Authors:  Cheng-Wu Zhao; Yu-Hang Gao; Wen-Xia Song; Bo Liu; Lu Ding; Ning Dong; Xin Qi
Journal:  Mediators Inflamm       Date:  2019-01-28       Impact factor: 4.711

4.  Effect of short-term high fat diet on resistin levels and expression of autophagy-related genes in the cartilage of male rats.

Authors:  Hebatallah Mohammed Aboudeya; Sara A Shaker; Mohammed Salama
Journal:  Sci Rep       Date:  2022-09-12       Impact factor: 4.996

Review 5.  Resistin, a Novel Host Defense Peptide of Innate Immunity.

Authors:  Yanran Li; Qiyuan Yang; Dongjie Cai; Hongrui Guo; Jing Fang; Hengmin Cui; Liping Gou; Junliang Deng; Zhisheng Wang; Zhicai Zuo
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 6.  Interplay Between the Immune and Endocrine Systems in the Lung: Implications for TB Susceptibility.

Authors:  Tariq Webber; Katharina Ronacher; Marli Conradie-Smit; Léanie Kleynhans
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.